Impax Laboratories downgraded

Impax Laboratories (IPXL -0.1%) catches a downgrade to Underperform from Neutral at Buckingham Research.

Price target is $15 (unchanged from previous), nearly 31% below Friday's close.

From other sites
Comments (1)
  • Nobs
    , contributor
    Comment (1) | Send Message
    Not surprisng, considering the turmoil inside the company.
    12 Aug 2013, 03:28 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs